AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kiaxone 250mg Injection

Prescription Icon
Prescription Required

Marketer

Alicanto Drugs Pvt Ltd

Salt Composition

Ceftriaxone (250mg)

Overview Kiaxone 250mg Injection

Cephalosporin antibiotic Cefixime 250mg Injection combats various bacterial infections. Its applications include treating infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, blood, and heart. Prophylactically, it can prevent surgical site infections. Administered intravenously or intramuscularly by a healthcare provider, dosage is determined individually. Consistent, evenly-spaced dosing, as directed, is crucial; premature cessation may result in infection recurrence or exacerbation. Common side effects, usually mild, comprise diarrhea, rash, altered liver function test results, and variations in blood cell counts (e.g., elevated eosinophils, leukopenia, thrombocytopenia). Injection site redness or soreness may temporarily occur. Report persistent or bothersome side effects to your physician. Prior to treatment, disclose any antibiotic allergies, kidney or liver conditions, and all concurrent medications to your doctor, as interactions may exist.

Uses of Kiaxone 250mg Injection

Managing Bacterial Infections

Major Benefits of Kiaxone 250mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Kiaxone 250mg Injection:

  • Diarrhea
  • Abnormal liver function tests
  • Rash
  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count
  • Low blood platelets

How to use Kiaxone 250mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Kiaxone 250mg Injection works:

Kiaxone 250mg Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial survival.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concomitant use of alcohol and Kiaxone 250mg Injection.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Kiaxone 250mg Injection is considered safe. The majority of research indicates minimal or negligible fetal risk.

Breast feedingBreast feedingCAUTION

Administering Kiaxone 250mg Injection to breastfeeding mothers requires careful consideration. It is recommended to discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.

DrivingDrivingUNSAFE

Administration of Kiaxone 250mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.

KidneyKidneySAFE IF PRESCRIBED

Kiaxone 250mg Injection can be administered to patients with kidney disease without altering the dosage. Nevertheless, disclosure of any pre-existing renal impairment to the prescribing physician is advised.

LiverLiverCAUTION

Exercise caution when administering Kiaxone 250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Kiaxone 250mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.

What if you forget to take Kiaxone 250mg Injection :

Omit a Kiaxone 250mg Injection dose? Seek your physician's advice.

Facts to Know About Kiaxone 250mg Injection

LabelValue
Type of Compound Extended-coverage cephalosporins (third and fourth generation)
Potential for Dependence None.
Medication Classification Antimicrobial agents

FAQs on Kiaxone 250mg Injection

Administering Kiaxone 250mg Injection is safe when following your physician's prescribed dosage and schedule. Strictly adhere to the recommended usage and avoid missed doses. Closely observe your doctor's guidance and report any concerning adverse reactions.
The effects of a 250mg Kiaxone injection typically begin shortly after administration. Complete eradication of the infection and resolution of symptoms, however, might require several days.
Patients with a known allergy to Kiaxone 250mg Injection or its components should avoid this medication. Pre-existing liver, kidney, gallbladder, or hematological conditions, including hemolytic anemia, must be disclosed to a physician before administration. Kiaxone 250mg Injection is contraindicated during pregnancy, breastfeeding, or when conception is planned, unless explicitly approved by a doctor to mitigate potential fetal harm. Complete disclosure of all concurrent medications is crucial, as drug interactions may occur.
Contact your physician if your condition doesn't improve after completing the prescribed medication regimen. Similarly, report any worsening of symptoms during treatment.
The typical duration of Kiaxone 250mg Injection in the body following cessation of treatment is approximately 48 hours.
The prescribed dose and duration of Kiaxone 250mg Injection are crucial for its effectiveness. Discontinuing treatment prematurely, even with noticeable improvement, may lead to symptom recurrence or exacerbation.
Kiaxone 250mg Injection requires administration by a qualified healthcare provider and should never be self-injected. Dosage is determined by your physician based on your specific medical needs. Adherence to your doctor's prescribed regimen is crucial for optimal therapeutic outcomes with Kiaxone 250mg Injection.
Kiaxone 250mg Injection
13
MRP 15
13% off